XML 22 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Commitments and Contingencies - Additional Information (Detail)
1 Months Ended 3 Months Ended
Mar. 31, 2019
USD ($)
Dec. 31, 2015
USD ($)
Nov. 30, 2015
USD ($)
shares
Mar. 31, 2020
USD ($)
ft²
Milestone
Mar. 31, 2019
USD ($)
Other Commitments [Line Items]          
Rental expense       $ 47,000 $ 49,000
Area of office space | ft²       5,197  
Lease expiration date       Sep. 30, 2021  
Remaining term of office lease       1 year 6 months  
Debt outstanding       $ 0  
Number of milestones achieved | Milestone       0  
Milestone payment $ 300,000        
Indemnification obligations amount       $ 0  
Contingent liabilities       $ 0  
License Agreement [Member]          
Other Commitments [Line Items]          
Sales based milestone payment   $ 36,000,000      
Royalty payment period   8 years      
License Agreement [Member] | Maximum [Member]          
Other Commitments [Line Items]          
Development and regulatory milestone payments   $ 42,100,000      
License Agreement [Member] | Minimum [Member]          
Other Commitments [Line Items]          
Sales required to achieve milestone payment   1,000,000,000      
Office of Chief Scientist of Israeli Ministry of Economy and Industry [Member]          
Other Commitments [Line Items]          
Grants received   $ 537,000      
Scientific Development and Research, Inc. and Otodyne, Inc. [Member] | License Agreement [Member]          
Other Commitments [Line Items]          
License fees paid     $ 750,000    
Share issued as consideration | shares     9,780